IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 119 filers reported holding IMMUNITYBIO INC in Q2 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,509 | +35.5% | 28,705 | +122.9% | 0.00% | – |
| Q2 2023 | $35,798 | -16.3% | 12,878 | -45.2% | 0.00% | – |
| Q1 2023 | $42,791 | -67.8% | 23,513 | -9.8% | 0.00% | – |
| Q4 2022 | $133,000 | -24.4% | 26,069 | -26.1% | 0.00% | – |
| Q3 2022 | $176,000 | +44.3% | 35,282 | +8.5% | 0.00% | – |
| Q2 2022 | $122,000 | +76.8% | 32,519 | +162.4% | 0.00% | – |
| Q1 2022 | $69,000 | -2.8% | 12,391 | +6.5% | 0.00% | – |
| Q4 2021 | $71,000 | -77.0% | 11,637 | -63.4% | 0.00% | -100.0% |
| Q3 2021 | $309,000 | +66.1% | 31,821 | +144.1% | 0.00% | – |
| Q2 2021 | $186,000 | +82.4% | 13,038 | +205.3% | 0.00% | – |
| Q1 2021 | $102,000 | – | 4,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 226,916 | $383,488 | 0.76% |
| HARBOURVEST PARTNERS LLC | 335,709 | $567,348 | 0.19% |
| ALLEN HOLDING INC /NY | 687,571 | $1,161,995 | 0.16% |
| ARMISTICE CAPITAL, LLC | 3,476,000 | $5,874,440 | 0.09% |
| Clearwater Capital Advisors, LLC | 394,599 | $666,873 | 0.08% |
| SHEETS SMITH WEALTH MANAGEMENT | 273,879 | $462,856 | 0.07% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $162,972 | 0.06% |
| WEALTH EFFECTS LLC | 53,500 | $90,415 | 0.04% |
| Virtus ETF Advisers LLC | 34,461 | $58,239 | 0.04% |
| FISHMAN JAY A LTD/MI | 162,000 | $273,780 | 0.04% |